Indonesia Alcohol Addiction Therapeutics Market Report 2022 to 2030

Indonesia Alcohol Addiction Therapeutics Market Analysis

$ 3999

The Indonesia Alcohol Addiction Therapeutics Market is valued at around $4 Mn in 2022 and is projected to reach $7 Mn by 2030, exhibiting a CAGR of 6.3% during the forecast period. Increasing awareness campaigns, reduced stigma, expanding healthcare infrastructure, and a changing social landscape, drive the potential demand for addiction treatment services, especially among youth in Indonesia. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Indonesia are Elli Lily, Lundbeck, AstraZeneca, Indivior, Alkermes, TEVA Pharmaceuticals, Merck & Co., Kimia Farma, Kalbe Farma and Osotspa among others

ID: IN10IDPH428 CATEGORY: Pharmaceuticals GEOGRAPHY: Indonesia AUTHOR: Netal Patel

Buy Now

Indonesia Alcohol Addiction Therapeutics Market Executive Summary

The Indonesia Alcohol Addiction Therapeutics Market is valued at around $4 Mn in 2022 and is projected to reach $7 Mn by 2030, exhibiting a CAGR of 6.3% during the forecast period.

Alcohol addiction, commonly referred to as alcohol use disorder (AUD), is a persistent medical condition characterized by an inability to control alcohol consumption despite adverse consequences. Individuals experiencing alcoholism exhibit a strong desire to drink, irrespective of its detrimental impact on personal, work, and social aspects of their lives. The specific causes of alcohol dependency are intricate and vary among individuals, involving factors like genetics, brain chemistry, mental health issues, and environmental influences. Overcoming alcoholism necessitates a comprehensive approach. While detoxification addresses withdrawal symptoms, behavioural therapies like Cognitive Behavioural Therapy (CBT) focus on modifying underlying thought patterns and triggers. Medications, such as naltrexone, aid in managing cravings and preventing relapse. Support groups like Alcoholics Anonymous (AA) offer a safe setting for encouragement and accountability.

In Indonesia, heavy episodic drinking (HED) is more common among people aged 15 and above, accounting for 6.5% of the population. Adolescents and young adults are especially prone to HED, with studies indicating rates as high as 23.3% among early teens (ages 11 to 14). Men drink more than women, with 6.5% and 1.4% reporting alcohol usage in the previous year, respectively. Increasing awareness campaigns, reduced stigma, expanding healthcare infrastructure, and a changing social landscape, drive the potential demand for addiction treatment services, especially among youth in Indonesia.

Companies like Eli Lilly, Lundbeck, and AstraZeneca use the strength of existing brands such as Revia, Campral, and Vivitrol. Their broad experience and research clout offer them a solid foundation. Kimia Farma and Kalbe Farma, Indonesia's pharmaceutical giants, use their local presence and generic medicine manufacturing to reach a larger audience.

Market Dynamics

Market Drivers

Increasing Awareness of Alcohol Addiction: BNN (Badan Narkotika Nasional) and non-governmental organizations (NGOs) such as Yayasan Kusuma are actively promoting awareness about alcohol addiction and its repercussions via different projects across Indonesia. Furthermore, increased media attention and open discussions about addiction are reducing stigma and encouraging people to seek treatment. As knowledge of mental health concerns grows, the relationship between addiction and mental health conditions becomes more apparent, resulting in a greater demand for treatment.

Expanding Healthcare Infrastructure: The Indonesian government is investing in healthcare facilities and increasing access to addiction treatment treatments. Private hospitals and clinics are increasingly providing addiction treatment services to a broader spectrum of individuals. Telemedicine platforms and internet therapy services have made addiction treatment more accessible.

Changing Social Landscape: The urbanization of lifestyles, as well as increased social pressures, might contribute to alcohol consumption. Rising disposable income among some groups of the population may result in increased spending on healthcare, especially addiction treatment. Studies that show a high incidence of HED among adolescents and young people point to a possible future demand for addiction treatment services.

Market Restraints

Lack of Insurance Coverage: Indonesian health insurance schemes generally exclude or provide limited coverage for addiction treatment, leaving patients with financial burdens. Many people are unaware of possible insurance coverage choices for addiction treatment, which further limits access. Limited laws on alcohol advertising, taxes, and the minimum drinking age may all lead to increasing alcohol use and addiction. The lack of a coherent national policy framework for combating alcohol addiction impedes efficient resource allocation and program execution.

Uneven distribution of services: Treatment facilities and skilled specialists are primarily concentrated in cities, leaving rural communities with little access. Addiction treatment can be costly, particularly for long-term programs or private facilities, posing financial challenges for many people. The shortage of addiction treatment-trained healthcare personnel further restricts the service availability and quality.

Stigma and Social Barriers: The social stigma associated with addiction, particularly in respect to religious views, might discourage people from getting treatment. Concerns about job loss, social exclusion, and family humiliation all pose substantial hurdles to treatment access. Limited public knowledge of addiction as a curable medical illness contributes to stigma and discourages people from seeking assistance.

Healthcare Policies and Regulatory Landscape

Indonesia's healthcare landscape is shaped by its Universal Health Coverage Program (JKN), a multifaceted initiative aiming for equitable access to essential services. JKN leverages mandatory insurance contributions and covers a broad spectrum of care, including cancer treatment. Notably, Indonesia's decentralized system empowers local governments while emphasizing primary care and traditional medicine integration. This approach prioritizes prevention and early detection, crucial in tackling widespread challenges like underfunded JKN, uneven access across urban and rural areas, and healthcare worker shortages. In the realm of drug regulation, the National Agency for Drug and Food Control (BPOM) reigns supreme. From registration and manufacturing oversight to quality control and pricing mechanisms, BPOM safeguards drug safety and affordability. Lengthy registration processes, bureaucratic hurdles, and fluctuating regulations often test the patience of pharmaceutical companies.

Competitive Landscape

Key Players

Elli Lily
Lundbeck
AstraZeneca
Indivior
Alkermes
TEVA Pharmaceuticals
Merck & Co.
Kimia Farma
Kalbe Farma
Osotspa

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Indonesia Alcohol Addiction Therapeutics Market Segmentation

By Therapy Type

Pharmacological Therapy
Behavioural Therapy
Digital Health Interventions
Others

By Disease Stage

Mild Alcohol Dependence
Moderate Alcohol Dependence
Severe Alcohol Dependence

By Route of Administration

Oral
Parenteral
Topical
Others

By Distribution Channel

Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies

By End User

In-Patient Centres
Out-Patient Speciality Clinics
Residential Treatment Centres
Homecare
Others

Insights10 will provide you with the reports within 10 key parameters which are:

Market Overview
Market Growth Drivers & Restraints
Epidemiology of Disease Type
Market Segmentation
Market Share
Competitive Landscape
Key Company Profiles
Healthcare Policies & Regulatory Framework
Reimbursement Scenario
Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

Establishing market drivers and trends
Analyzing the regulatory landscape to understand future growth
Market Segment based analysis to obtain revenue/volume
Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.